✦ LIBER ✦

Placebo-controlled double-blind cross-over study of botulinum A toxin in hemifacial spasm

✍ Scribed by Niphon Poungvarin; Adulya Viriyavejakul; Chulaluk Komoltri

Book ID: 116175194
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 331 KB
Volume: 1
Category: Article
ISSN: 1353-8020
DOI: 10.1016/1353-8020(95)00003-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Double-blind placebo-controlled study of

Double-blind placebo-controlled study of intradermal botulinum toxin A in chronic pain

✍ E. Chevlen 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Quantitative EMG in botulinum toxin trea

Quantitative EMG in botulinum toxin treatment of cervical dystonia. A double-blind, placebo-controlled study

✍ L. Østergaard; A. Fuglsang-Frederiksen; L. Werdelin; O. Sjö; H. Winkel 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 499 KB

Naltrexone augmentation in OCD: A double

Naltrexone augmentation in OCD: A double-blind placebo-controlled cross-over study

✍ Revital Amiaz; Leah Fostick; Ari Gershon; Joseph Zohar 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 334 KB

Botulinum toxin A in the prophylactic tr

Botulinum toxin A in the prophylactic treatment of migraine – a randomized, double-blind, placebo-controlled study

✍ S Evers; J Vollmer-Haase; S Schwaag; A Rahmann; I-W Husstedt; A Frese 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

Cyclandelate in diabetic neuropathy. A d

Cyclandelate in diabetic neuropathy. A double-blind, placebo-controlled, randomized, cross-over study

✍ J. J. Hemans; B. Drukarch; I. Matthaei; G. A. Liff; F. W. Bertelsmann; R. L. M. 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 362 KB

Botulinum toxin type A for drooling in P

Botulinum toxin type A for drooling in Parkinson's disease: A double-blind, randomized, placebo-controlled study

✍ Giovanni Lagalla; Marzia Millevolte; Marianna Capecci; Leandro Provinciali; Mari 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

To investigate the safety and efficacy of botulinum toxin type A (BoNTX) treatment to reduce sialorrhea in Parkinson's disease (PD), a double-blind, randomized, placebo-controlled study enrolled 32 PD patients complaining of excessive drooling. Patients received either 50 U Botox in each parotid gla